Atrium Therapeutics

Lead market readiness and medical strategy for rare cardiomyopathies, focusing on market shaping, KOL engagement, and scientific exchange. Act as a strategic partner to the CSO to drive pipeline prioritization and competitive intelligence.

Lead the development and execution of integrated corporate communications and investor relations strategies to strengthen relationships with external and internal stakeholders. Manage investor interactions, media engagement, digital presence, and executive messaging to amplify the company's scientific approach and business progress.

This role is responsible for developing and executing a comprehensive patient advocacy strategy, serving as the primary contact for advocacy groups, and ensuring the patient voice is integrated across clinical development, regulatory affairs, and communications. The director will also support the development of public health policy priorities focusing on patient access and health equity.